Most peptides targeted by TCR-T cells tested in humans so far derive from cancer germline antigens (CGAs) [186], which are highly expressed in cancer and reproductive organs, such as MAGEA4 or CTAG1B, coding for the NY-ESO-1 protein [27, 30]. The gene discussed is MAGEA4; the disease is cancer.